The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

When overall survival data are evaluated, a numerical trend toward shorter survival times in the HER3-positive group was observed, consistent with the literature, though statistical significance was not reached.

also in 708 other papers

7.1 months; p = 0.285); however, this difference did not reach statistical significance and should be interpreted with caution given the small sample size.

also in 61,332 other papers

14.2 months), whereas those receiving TKI in the second line showed a trend toward longer OS in HER3-positive patients (20.5 vs. 17.2 months).

also in 31,039 other papers